CN101454328A - 新的mch受体拮抗剂 - Google Patents

新的mch受体拮抗剂 Download PDF

Info

Publication number
CN101454328A
CN101454328A CNA2007800195489A CN200780019548A CN101454328A CN 101454328 A CN101454328 A CN 101454328A CN A2007800195489 A CNA2007800195489 A CN A2007800195489A CN 200780019548 A CN200780019548 A CN 200780019548A CN 101454328 A CN101454328 A CN 101454328A
Authority
CN
China
Prior art keywords
phenyl
thieno
chloro
pyridin
methoxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800195489A
Other languages
English (en)
Chinese (zh)
Inventor
M·B·阿诺尔德
Y·道
K·M·伽丁尼尔
D·J·加尔门
S·J·格林
E·J·亨布雷
陆建良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN101454328A publication Critical patent/CN101454328A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2007800195489A 2006-06-08 2007-06-08 新的mch受体拮抗剂 Pending CN101454328A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
US60/811,841 2006-06-08

Publications (1)

Publication Number Publication Date
CN101454328A true CN101454328A (zh) 2009-06-10

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800195489A Pending CN101454328A (zh) 2006-06-08 2007-06-08 新的mch受体拮抗剂

Country Status (10)

Country Link
US (2) US8263772B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029609A2 (cg-RX-API-DMAC7.html)
JP (1) JP5198439B2 (cg-RX-API-DMAC7.html)
CN (1) CN101454328A (cg-RX-API-DMAC7.html)
AU (1) AU2007257922A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2652385A1 (cg-RX-API-DMAC7.html)
EA (1) EA015127B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008015662A (cg-RX-API-DMAC7.html)
WO (1) WO2007146758A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114286818A (zh) * 2019-07-02 2022-04-05 诺维逊生物股份有限公司 作为bet抑制剂的杂环化合物

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102264737A (zh) * 2008-12-23 2011-11-30 雅培制药有限公司 抗病毒化合物
RU2505539C2 (ru) 2008-12-23 2014-01-27 Эбботт Лэборетриз Антивирусные соединения
BRPI0923527A2 (pt) 2008-12-24 2016-08-09 Syngenta Ltd métodos de preparo de fungicidas
WO2010120935A1 (en) * 2009-04-15 2010-10-21 Abbott Laboratories Anti-viral compounds
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
EP2853531A3 (en) * 2009-06-11 2015-08-12 AbbVie Bahamas Ltd. Antiviral compounds
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
BR112014027133A2 (pt) 2012-05-09 2017-06-27 Basf Se compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
PT2970205T (pt) 2013-03-14 2019-08-26 Tolero Pharmaceuticals Inc Inibidores da jak2 e da alk2 e métodos para a sua utilização
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
PE20180572A1 (es) 2015-06-18 2018-04-04 Cephalon Inc Derivados de piperidina 1,4-sustituidos
EP3310773B1 (en) 2015-06-18 2020-12-02 89Bio Ltd. Substituted 4-benzyl and 4-benzoyl piperidine derivatives
KR20210038906A (ko) 2018-07-26 2021-04-08 스미토모 다이니폰 파마 온콜로지, 인크. 비정상적 acvr1 발현과 연관된 질환을 치료하는 방법 및 그에 사용하기 위한 acvr1 억제제
EP3873474A4 (en) 2018-10-30 2022-07-13 Nuvation Bio Inc. HETEROCYCLIC COMPOUNDS USED AS BET INHIBITORS
WO2024020034A1 (en) * 2022-07-20 2024-01-25 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
WO2005047293A1 (en) 2003-11-07 2005-05-26 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0507629A (pt) * 2004-02-13 2007-07-03 Banyu Pharma Co Ltd composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
US20050256124A1 (en) * 2004-04-15 2005-11-17 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
BRPI0512252A (pt) 2004-06-18 2008-02-19 Biolipox Ab composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
ATE446962T1 (de) * 2004-12-17 2009-11-15 Lilly Co Eli Thiazolopyridinon-derivate als mch- rezeptorantagonisten
CA2636617A1 (en) * 2006-02-15 2007-08-23 Lothar Schwink Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
RU2008136898A (ru) * 2006-02-15 2010-03-20 Санофи-Авентис (Fr) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114286818A (zh) * 2019-07-02 2022-04-05 诺维逊生物股份有限公司 作为bet抑制剂的杂环化合物

Also Published As

Publication number Publication date
WO2007146758A3 (en) 2008-02-07
US8263772B2 (en) 2012-09-11
JP5198439B2 (ja) 2013-05-15
US20090093456A1 (en) 2009-04-09
EA200870517A1 (ru) 2009-04-28
CA2652385A1 (en) 2007-12-21
BRPI0712680A2 (pt) 2012-11-20
WO2007146758A2 (en) 2007-12-21
AU2007257922A1 (en) 2007-12-21
US20120302547A1 (en) 2012-11-29
EA015127B1 (ru) 2011-06-30
JP2009539875A (ja) 2009-11-19
EP2029609A2 (en) 2009-03-04
MX2008015662A (es) 2009-01-12

Similar Documents

Publication Publication Date Title
US7812017B2 (en) 4-substituted indole and indoline compounds
US8263772B2 (en) MCH receptor antagonists
JP4754821B2 (ja) 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物
CN101426783B (zh) 作为11-β-羟基甾族化合物脱氢酶1的抑制剂的环己基吡唑-内酰胺衍生物
US6380238B1 (en) Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands
US20110015185A1 (en) Benzofuran Compounds
TWI557110B (zh) 作為5-ht6拮抗劑的芳基磺醯基吡唑啉羧脒衍生物
WO2003062205A1 (en) 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
AU2008256859A1 (en) 4' substituted compounds having 5-HT6 receptor affinity
JP2009507037A (ja) 5−HT2C受容体アゴニストとしての6−置換された2,3,4,5−テトラヒドロ−1H−ベンゾ[d]アゼピン
JP2024028642A (ja) カンナビノイド受容体部分アゴニストとしてのインダゾール誘導体
CN101321765A (zh) 可用作vr1受体拮抗剂的苯并吡喃酮衍生物
CN104884436B (zh) 苯并氮杂衍生物及其医药用途
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
KR20260035942A (ko) 만성 통증 치료를 위한 gpr183 길항제로서의 2-페녹시-1-(4-(알킬설포닐)피페리딘-1-일)에탄-1-온 및 3-페닐-1-(4-(알킬설포닐)피페리딘-1-일)프로프-2-엔-1-온 유도체
JP2017525734A (ja) 癌の治療において有用なイソキノリノン誘導体
CN119790048A (zh) 新颖的取代的四氢异喹啉-6-甲酸衍生物、用于其制备的方法及其治疗用途
CN100522161C (zh) 作为大麻素cb1受体的激动剂的(吲哚-3-基)-杂环衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20090610

C20 Patent right or utility model deemed to be abandoned or is abandoned